Chris Vickers, global sales manager at Optimal Industrial Technologies, looks at the financial benefits of adopting PAT to enhance the competitiveness of pharmaceutical manufacturers.
In this second article devoted to analysing issues that need to be brought to the forefront of public awareness to support the femtech market, Josephine Ornago, owner at OutspokenPR, addresses the issue of pain in women’s health issues.
In the fast-paced world of medical technology, the demand for reliable and high-quality power solutions and advanced display technologies has never been greater.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications hails the issuing of the latest version of the new model for assessing value based procurement.
Sarah Knight, head of healthcare technology at 42 Technology (42T), argues that until more women can be encouraged to pursue engineering and design as a career, then the full potential of innovation in women’s health will never be realised.
Olivia Dias, digital designer at creative agency Driftime, explains why founder stories and connecting with audiences across digital touchpoints are essential for FemTech success.
Josephine Ornago, owner at OutspokenPR, creates a four-part series to raise awareness for the femtech market. This series starts with the critical issue of the destigmatisation of the female reproductive apparatus in its entirety.
Following the fund’s first 10 investments, Emma Palmer Foster, Director of Discovery Park Ventures, and Martino Picardo, Director of DPV and Chairman of Discovery Park, share their learnings and insights into life science investing.
In this article, Nick Allen, CEO at 3DPRINTUK and Neil Sewell, CEO, Solid Print3D will explore the decision-making for engaging with 3D printing, whether that is for in-house 3D printing or outsourcing to service providers.
